This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A Virus Hemagglutinin (H7), His
Product Overview
BioVenic's Recombinant Influenza A Virus Hemagglutinin (H7), His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 62.2 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The hemagglutinin (H7) of influenza A virus is a key surface protein of the H7 subtype, responsible for binding to host cell receptors and mediating viral entry. In veterinary medicine, H7 subtype avian influenza viruses are highly pathogenic to poultry, causing severe outbreaks. The H7 hemagglutinin is an important target for vaccine development, as it induces antibodies that neutralize the virus and provide immune protection. Additionally, the H7 hemagglutinin is used in diagnostic tests to rapidly identify infections by detecting antibodies in serum. Studies have shown that the receptor-binding properties and stability of the H7 hemagglutinin influence viral transmission and pathogenicity. Therefore, the H7 hemagglutinin plays a significant role in the prevention and control of avian influenza.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.